2Smith AG, Cornblath WT, Deveikis JP. Local thrombolytic therapy in deep cerebral venous thrombosis. Neurology, 1997, 48(6): 1613-1619.
3Najim al Din AS, Mubaidin A, Wriekat AL, et al. Risk factors of aseptic intracranial venous occlusive disease. Acta Neurol Scand, 1994,90(6): 412-416.
4Wechsler B, Vidailhet M, Piette JC, et al. Cerebral venous thrombosis in Behcet' s disease: clinical study and long-term follow-up of 25 cases.Neurology, 1992, 42(3 pt 1): 614-618.
5Crawford SC, Digre KB, Palmer CA, et al. Thrombosis for the deep venous drainage of the brain in adults. Analysis of seven cases with review of the literature. Arch Neurol, 1995,52 ( 11 ): 1101-1108.
7Brucker AB, Vollert Rogenhofer H, Wagner M, et al. Heparin treatment in acute cerebral sinus venous thrombosis: a retrospective clinical and MR analysis of 42 cases. Cerebrovasc Dis, 1998, 8(6): 331-337.
8Einhaupl KM, Villringer A, Meister W, et al. Cerebral venous thrombosis: nothing, heparin, or local thrombolysis? Stroke, 1999, 30(3):481483.
9Einhanpl KM, Villringer A, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet, 1991, 338(8767): 597-600.
10The Columbus Investigators. Low-moleeular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med, 1997,337(10): 657-662.
